Market Overview

Apricus Biosciences +31% Premarket @$1.98; Co Announced Approval of Vitaros in Mexico to Treat ED

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News FDA Pre-Market Outlook Movers

 

Related Articles (APRI)